<DOC>
	<DOCNO>NCT00418522</DOCNO>
	<brief_summary>This study determine inhale insulin effective treat type 2 diabetes mellitus .</brief_summary>
	<brief_title>This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Age &gt; 30 year â‰¤ 75 year diagnosis type 2 diabetes mellitus make &gt; 6 month prior study entry Screening HbA1c &gt; 7.0 % Currently treat stable dose least 2 oral antidiabetic agent least 3 month prior study entry ; include sulfonylurea and/or metformin , and/or thiazolidinedione Smoking within last 6 month PFTs outside range Type 1 diabetes mellitus Type 2 diabetes mellitus currently ( last three month ) treat insulin regimen ( alone Oral Antidiabetic Agents ) Active liver disease ; significantlyimpaired hepatic function , show , limited , alanine aminotransferase ( ALT ) serum glutamic pyruvic transaminase ( SGPT ) aspartate transaminase ( AST ) serum glutamicoxaloacetic transaminase ( SGOT ) 2x upper limit normal measure visit 1 . However , patient elevate ALT &gt; 1.5 upper limit normal result hepatic steatosis permit enter study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Insulin Glargine Diabetes HbA1c</keyword>
</DOC>